The application of genome editing in studying hearing loss.

Abstract

Targeted genome editing mediated by clustered, regularly interspaced, short palindromic repeat (CRISPR)/CRISPR-associated nuclease 9 (Cas9) technology has emerged as one of the most powerful tools to study gene functions, and with potential to treat genetic disorders. Hearing loss is one of the most common sensory disorders, affecting approximately 1 in 500… (More)
DOI: 10.1016/j.heares.2015.04.016

Topics

3 Figures and Tables

Statistics

05020162017
Citations per Year

Citation Velocity: 18

Averaging 18 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Slides referencing similar topics